Liver cancer: expression features of hepatitis B antigens
Introduction. Hepatocellular carcinoma (HCC) is currently the fifth most common malignancy in men and the eighth in women worldwide. According to the latest European Union countries’ statistics the incidence of HC cancer is about 8,29 per 100000 accidents, cholangiocellular (CC) cancer – 0,9-1,3 pe...
| Published in: | Patologìâ |
|---|---|
| Main Authors: | V. A. Tumanskiy, M. D. Zubko |
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2013-12-01
|
| Subjects: | |
| Online Access: | http://pat.zsmu.edu.ua/article/view/22357/19988 |
Similar Items
HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment
by: Maurizio Salvadori, et al.
Published: (2020-11-01)
by: Maurizio Salvadori, et al.
Published: (2020-11-01)
Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion
by: Takanori Suzuki, et al.
Published: (2025-09-01)
by: Takanori Suzuki, et al.
Published: (2025-09-01)
Yeast-Derived Glucan Particles: Biocompatibility, Efficacy, and Immunomodulatory Potential as Adjuvants and Delivery Systems
by: João Panão-Costa, et al.
Published: (2025-08-01)
by: João Panão-Costa, et al.
Published: (2025-08-01)
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-11-01)
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-11-01)
The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-12-01)
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-12-01)
Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!
by: R N Makroo, et al.
Published: (2012-01-01)
by: R N Makroo, et al.
Published: (2012-01-01)
Production of the HBc Protein from Different HBV Genotypes in <i>E. coli</i>. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
by: Ivars Petrovskis, et al.
Published: (2021-01-01)
by: Ivars Petrovskis, et al.
Published: (2021-01-01)
Mutational landscape of the surface antigen of hepatitis B virus in patients with hepatocellular carcinoma
by: Arwa Bagasi, et al.
Published: (2025-06-01)
by: Arwa Bagasi, et al.
Published: (2025-06-01)
An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression
by: Giuseppina Brancaccio, et al.
Published: (2021-04-01)
by: Giuseppina Brancaccio, et al.
Published: (2021-04-01)
Seropositivity of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative vaccinated individuals aged 5–12 years in North West Ethiopia
by: Adane Adugna, et al.
Published: (2024-11-01)
by: Adane Adugna, et al.
Published: (2024-11-01)
Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)
A Comparative study on the prevalence of HCC seromarkers among tribal and coastal population
by: Joseph Selvin, et al.
Published: (2010-03-01)
by: Joseph Selvin, et al.
Published: (2010-03-01)
The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia
by: Christina Safira Whinie Lestari, et al.
Published: (2023-05-01)
by: Christina Safira Whinie Lestari, et al.
Published: (2023-05-01)
Status of Hepatitis Be Antigen in Chronic Hepatitis B Patients from Various Regions of Pakistan
by: Agha Babar Hussain
Published: (2017-09-01)
by: Agha Babar Hussain
Published: (2017-09-01)
New perspectives of biomarkers for the management of chronic hepatitis B
by: Chih-Lin Lin, et al.
Published: (2016-12-01)
by: Chih-Lin Lin, et al.
Published: (2016-12-01)
Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy
by: Biyu Liu, et al.
Published: (2023-03-01)
by: Biyu Liu, et al.
Published: (2023-03-01)
Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China
by: Yijun Wang, et al.
Published: (2023-12-01)
by: Yijun Wang, et al.
Published: (2023-12-01)
Comparative ELISA reagents for detection of hepatitis B surface antigen (HBsAg) Comparação de reativos para o teste de ELISA na evidenciação do antígeno de superfície de hepatite B
by: I. F. Camargo, et al.
Published: (1987-06-01)
by: I. F. Camargo, et al.
Published: (1987-06-01)
Hepatitis surface B antigen clearance induced by long-term tenofovir disoproxil fumarate monotherapy in chronic hepatitis B treatment: a meta-analysis and longitudinal modeling analysis
by: Weizhe Jian, et al.
Published: (2025-05-01)
by: Weizhe Jian, et al.
Published: (2025-05-01)
Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
by: Carla S. Coffin, et al.
Published: (2022-11-01)
by: Carla S. Coffin, et al.
Published: (2022-11-01)
Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)
Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
by: C Niederhauser, et al.
Published: (2008-03-01)
by: C Niederhauser, et al.
Published: (2008-03-01)
Hepatitis B Virus Genotype H: Epidemiological, Molecular, and Clinical Characteristics in Mexico
by: Arturo Panduro, et al.
Published: (2023-10-01)
by: Arturo Panduro, et al.
Published: (2023-10-01)
Seroprevalence and sociodemographic determinants of HBsAg and Anti-HBC in Malaysia's nationwide population
by: Nurfatehar Ramly, et al.
Published: (2025-09-01)
by: Nurfatehar Ramly, et al.
Published: (2025-09-01)
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
by: Milan J. Sonneveld, et al.
Published: (2023-08-01)
by: Milan J. Sonneveld, et al.
Published: (2023-08-01)
Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
by: Gian Paolo Caviglia, et al.
Published: (2021-11-01)
by: Gian Paolo Caviglia, et al.
Published: (2021-11-01)
Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)
by: Joonhong Park, et al.
Published: (2021-11-01)
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)
Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia
by: Marina Bubonja-Šonje, et al.
Published: (2024-01-01)
by: Marina Bubonja-Šonje, et al.
Published: (2024-01-01)
A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?
by: Laura Escolà-Vergé, et al.
Published: (2017-07-01)
by: Laura Escolà-Vergé, et al.
Published: (2017-07-01)
Prevalence of Hepatitis B Serum Markers in Young Military Recruits in Greece: A Comparison Study between 2005 and 2019 Cohorts
by: Nikolaos Papadopoulos, et al.
Published: (2021-11-01)
by: Nikolaos Papadopoulos, et al.
Published: (2021-11-01)
A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion
by: Chongwei Xie, et al.
Published: (2025-03-01)
by: Chongwei Xie, et al.
Published: (2025-03-01)
Hepatitis B Virus Seroprevalence in Ayacucho, Peru: A Comprehensive Review Across the Pre-Vaccination and Post-Vaccination Periods
by: Homero Ango-Aguilar, et al.
Published: (2025-08-01)
by: Homero Ango-Aguilar, et al.
Published: (2025-08-01)
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)
by: Romina Salpini, et al.
Published: (2020-01-01)
Epidemiology of Chronic Hepatitis B Infection in the Cohort of College Students with Vaccination in Taiwan
by: Te-Wei Cheng, et al.
Published: (2023-02-01)
by: Te-Wei Cheng, et al.
Published: (2023-02-01)
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
by: Widad Yazaji, et al.
Published: (2016-09-01)
by: Widad Yazaji, et al.
Published: (2016-09-01)
Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Xiao Lin, et al.
Published: (2022-09-01)
by: Xiao Lin, et al.
Published: (2022-09-01)
Potential infectivity of blood from HBsAG asymptomatic carriers due to the presence of HBV-DNA and comparison with other markers of hbv infection Potencial de infectividade em sangue de portadores assintomáticos de HBsAg caracterizado pela presença de HBV-DNA e comparação com outros marcadores da Hepatite B.
by: M. Valeria Tedeschi, et al.
Published: (1989-12-01)
by: M. Valeria Tedeschi, et al.
Published: (1989-12-01)
Systematic Optimization of Protein Secretory Pathways in Saccharomyces cerevisiae to Increase Expression of Hepatitis B Small Antigen
by: Jiayuan Sheng, et al.
Published: (2017-05-01)
by: Jiayuan Sheng, et al.
Published: (2017-05-01)
PEMERIKSAAN HEPATITIS B SURFACE ANTIGEN (HBsAg) DAN Anti-HBs PADA IBU HAMIL
by: Herlando Sinaga, et al.
Published: (2018-12-01)
by: Herlando Sinaga, et al.
Published: (2018-12-01)
Similar Items
-
HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment
by: Maurizio Salvadori, et al.
Published: (2020-11-01) -
Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion
by: Takanori Suzuki, et al.
Published: (2025-09-01) -
Yeast-Derived Glucan Particles: Biocompatibility, Efficacy, and Immunomodulatory Potential as Adjuvants and Delivery Systems
by: João Panão-Costa, et al.
Published: (2025-08-01) -
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-11-01) -
The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-12-01)
